Bicara Therapeutics Looks To Reclaim Some Of The Spotlight From Merus

Group 1 - May 23 marked a significant day for patients, oncologists, and investors in the treatment of head and neck cancer, with key presentations scheduled at the American Society of Clinical Oncology (ASCO) [1] - Bicara Therapeutics Inc. is involved in the development of treatments for head and neck cancer, indicating potential investment opportunities in this sector [1]